Home > Insider Trading > Filing (0001214659-22-015441)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1677077	Alzamend Neuro Inc.	ALZN	()	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1212502	Iii C Milton Ault	11411 Southern Highlands Parkway Suite 240 Las Vegas NV 89141		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-12-27	900	$0.59	11,046,901	No	4	P	Indirect	By Ault Lending, LLC
Common Stock	Acquisiton	2022-12-28	3,100	$0.56	11,050,001	No	4	P	Indirect	By Ault Lending, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Ault Lending, LLC
No	4	P	Indirect	By Ault Lending, LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,500,000	Direct
Common Stock	365,000	Indirect	By Ault Alpha LP
Common Stock	14,942,984	Indirect	By Ault Life Sciences, Inc.
Common Stock	10,000,000	Indirect	By Ault Life Sciences Fund, LLC

Footnotes

Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of BitNile Holdings, Inc. ("BH"). Mr. Ault, the Executive Chairman of BH, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.5629. The range of purchase prices on the transaction date was $0.5594 to $0.5754 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
Milton C. Ault, III, is the Manager of Ault Alpha GP LLC ("Ault GP") and Ault Capital Management LLC ("AC Management"). Ault GP and AC Management are the general partner and investment manager to Ault Alpha LP, respectively. As such, Mr. Ault is deemed to beneficially own the shares held by Ault Alpha LP.
Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.